Lori Summers, MD
Neurological Surgery · Hammond, LANPI 1811943996
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $66,000 of the $66,993 with a category attached, or 98.5%. North Shore Surgical Services, LLC accounts for 98.5% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $66,442 and has fallen 100.0% since, to $21 in 2025.
Across 12 payments — averaging $5582.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- North Shore Surgical Services, LLC$66K
- Nevro Corp.$187
- Boston Scientific$186
- Si-bone, Inc.$148
- Stryker$144
- AbbVie$125
- plus $203 from 3 others
What the payments were for
- Food & beverage$9931%
- Ownership interest$66,00099%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| North Shore Surgical Services, LLC | 1 | $66,000 |
| Nevro Corp. | 2 | $187 |
| Boston Scientific | 2 | $186 |
| Si-bone, Inc. | 1 | $148 |
| Stryker | 2 | $144 |
| AbbVie | 1 | $125 |
| Johnson & Johnson | 1 | $107 |
| Medtronic | 1 | $74 |
| Innovation Technologies Inc | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IVS - MULTIGEN 2RF$125
- IVS - IVAS$125
- Creon$125
- XARELTO$107
- CLINICAL TRIAL PRODUCT$104
- Omnia$101
How this compares
$66,993 in reported general payments places this provider in the 80th percentile of 116 neurological surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 86 | $1,073 |
| Lidocaine | 12 | $977 |
| Gabapentin | 81 | $752 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $565 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 49 | $413 |
| Tizanidine Hcl | 31 | $338 |
| Methylprednisolone | 32 | $185 |
| Cyclobenzaprine Hcl | 24 | $175 |
| Amitriptyline Hcl | 19 | $158 |
| Tramadol Hcl | 33 | $71 |
| Ciprofloxacin Hcl | 14 | $46 |
| Meloxicam | 13 | $32 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Hammond
- Sebastian KogaHammond$720K
- Anthony SinShreveport$1.5M
- Eric OberlanderBaton Rouge$660K
- Najeeb ThomasMetairie$440K
- Gabriel TenderNew Orleans$255K
- Justin OwenMarrero$201K
- Daniel DenisKenner$198K
- Brian KelleyLake Charles$193K
- Jason CormierLafayette$178K
- Christopher MaulucciNew Orleans$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.